{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:47:17Z","timestamp":1789055237836,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Biotechnology, Government of India","award":["BT\/PR4268\/BRB\/10\/1016\/2011"],"award-info":[{"award-number":["BT\/PR4268\/BRB\/10\/1016\/2011"]}]},{"name":"Department of Biotechnology, Government of India","award":["BT\/PR12820\/BRB\/10\/726\/2009"],"award-info":[{"award-number":["BT\/PR12820\/BRB\/10\/726\/2009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11010-019-03661-1","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T13:51:29Z","timestamp":1575294689000},"page":"205-219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling"],"prefix":"10.1007","volume":"464","author":[{"given":"Md. Jahangir","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish R.","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6833-9113","authenticated-orcid":false,"given":"Shyamal K.","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"3661_CR1","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1210\/en.2017-00243","volume":"158","author":"LJ Fothergill","year":"2017","unstructured":"Fothergill LJ, Callaghan B, Hunne B et al (2017) Costorage of enteroendocrine hormones evaluated at the cell and subcellular levels in male mice. Endocrinology 158:2113\u20132123. https:\/\/doi.org\/10.1210\/en.2017-00243","journal-title":"Endocrinology"},{"key":"3661_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pneurobio.2017.04.003","volume":"154","author":"J Troger","year":"2017","unstructured":"Troger J, Theurl M, Kirchmair R et al (2017) Granin-derived peptides. Prog Neurobiol 154:37\u201361. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.04.003","journal-title":"Prog Neurobiol"},{"key":"3661_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fendo.2017.00020","volume":"8","author":"GK Bandyopadhyay","year":"2017","unstructured":"Bandyopadhyay GK, Mahata SK (2017) Chromogranin A regulation of obesity and peripheral insulin sensitivity. Front Endocrinol Lausanne 8:20. https:\/\/doi.org\/10.3389\/fendo.2017.00020","journal-title":"Front Endocrinol Lausanne"},{"key":"3661_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00018-014-1750-9","volume":"72","author":"KB Helle","year":"2015","unstructured":"Helle KB, Corti A (2015) Chromogranin A: a paradoxical player in angiogenesis and vascular biology. Cell Mol Life Sci CMLS 72:339\u2013348. https:\/\/doi.org\/10.1007\/s00018-014-1750-9","journal-title":"Cell Mol Life Sci CMLS"},{"key":"3661_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fchem.2014.00064","volume":"2","author":"B Tota","year":"2014","unstructured":"Tota B, Angelone T, Cerra MC (2014) The surging role of Chromogranin A in cardiovascular homeostasis. Front Chem 2:64. https:\/\/doi.org\/10.3389\/fchem.2014.00064","journal-title":"Front Chem"},{"key":"3661_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00424-017-2027-6","volume":"470","author":"KB Helle","year":"2018","unstructured":"Helle KB, Metz-Boutigue M-H, Cerra MC, Angelone T (2018) Chromogranins: from discovery to current times. Pflug Arch 470:143\u2013154. https:\/\/doi.org\/10.1007\/s00424-017-2027-6","journal-title":"Pflug Arch"},{"key":"3661_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2217\/bmm.13.102","volume":"8","author":"JP Goetze","year":"2014","unstructured":"Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF (2014) Chromogranin A as a biomarker in cardiovascular disease. Biomark Med 8:133\u2013140. https:\/\/doi.org\/10.2217\/bmm.13.102","journal-title":"Biomark Med"},{"key":"3661_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/EC-14-0017","volume":"3","author":"JP Goetze","year":"2014","unstructured":"Goetze JP, Hilsted LM, Rehfeld JF, Alehagen U (2014) Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure. Endocr Connect 3:47\u201356. https:\/\/doi.org\/10.1530\/EC-14-0017","journal-title":"Endocr Connect"},{"key":"3661_CR9","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1210\/en.2009-0429","volume":"150","author":"JR Gayen","year":"2009","unstructured":"Gayen JR, Gu Y, O\u2019Connor DT, Mahata SK (2009) Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse. Endocrinology 150:5027\u20135035. https:\/\/doi.org\/10.1210\/en.2009-0429","journal-title":"Endocrinology"},{"key":"3661_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/HJH.0b013e328336ed3e","volume":"28","author":"SM Vaingankar","year":"2010","unstructured":"Vaingankar SM, Li Y, Biswas N et al (2010) Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses. J Hypertens 28:817\u2013825. https:\/\/doi.org\/10.1097\/HJH.0b013e328336ed3e","journal-title":"J Hypertens"},{"key":"3661_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/B978-0-12-411512-5.00005-1","volume":"68","author":"R Borges","year":"2013","unstructured":"Borges R, Dominguez N, Smith CB et al (2013) Granins and catecholamines: functional interaction in chromaffin cells and adipose tissue. Adv Pharmacol 68:93\u2013113. https:\/\/doi.org\/10.1016\/B978-0-12-411512-5.00005-1","journal-title":"Adv Pharmacol"},{"key":"3661_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12031-012-9728-2","volume":"48","author":"YP Loh","year":"2012","unstructured":"Loh YP, Cheng Y, Mahata SK et al (2012) Chromogranin A and derived peptides in health and disease. J Mol Neurosci MN 48:347\u2013356. https:\/\/doi.org\/10.1007\/s12031-012-9728-2","journal-title":"J Mol Neurosci MN"},{"key":"3661_CR13","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170425100416","author":"SK Mahata","year":"2017","unstructured":"Mahata SK, Kiranmayi M, Mahapatra NR (2017) Catestain: a master regulator of cardiovascular functions. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867324666170425100416","journal-title":"Curr Med Chem"},{"key":"3661_CR14","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1523\/JNEUROSCI.5292-07.2008","volume":"28","author":"MS Montesinos","year":"2008","unstructured":"Montesinos MS, Machado JD, Camacho M et al (2008) The crucial role of chromogranins in storage and exocytosis revealed using chromaffin cells from CHROMOGRANIN A null mouse. J Neurosci 28:3350\u20133358. https:\/\/doi.org\/10.1523\/JNEUROSCI.5292-07.2008","journal-title":"J Neurosci"},{"key":"3661_CR15","doi-asserted-by":"publisher","first-page":"23141","DOI":"10.1074\/jbc.M111.335877","volume":"287","author":"GK Bandyopadhyay","year":"2012","unstructured":"Bandyopadhyay GK, Vu CU, Gentile S et al (2012) Catestatin (chromogranin A(352\u2013372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling. J Biol Chem 287:23141\u201323151. https:\/\/doi.org\/10.1074\/jbc.M111.335877","journal-title":"J Biol Chem"},{"key":"3661_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/1074248416628676","volume":"21","author":"D Wang","year":"2016","unstructured":"Wang D, Liu T, Shi S et al (2016) Chronic administration of catestatin improves autonomic function and exerts cardioprotective effects in myocardial infarction rats. J Cardiovasc Pharmacol Ther 21:526\u2013535. https:\/\/doi.org\/10.1177\/1074248416628676","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"3661_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3109\/1354750X.2014.950331","volume":"19","author":"Z Wu","year":"2014","unstructured":"Wu Z, Zhu D (2014) The important role of catestatin in cardiac remodeling. Biomark Biochem Indic Expo Response Susceptibility Chem 19:625\u2013630. https:\/\/doi.org\/10.3109\/1354750X.2014.950331","journal-title":"Biomark Biochem Indic Expo Response Susceptibility Chem"},{"key":"3661_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.niox.2015.07.004","volume":"50","author":"T Angelone","year":"2015","unstructured":"Angelone T, Quintieri AM, Pasqua T et al (2015) The NO stimulator, Catestatin, improves the Frank\u2013Starling response in normotensive and hypertensive rat hearts. Nitric Oxide 50:10\u201319. https:\/\/doi.org\/10.1016\/j.niox.2015.07.004","journal-title":"Nitric Oxide"},{"key":"3661_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3109\/10641960903265246","volume":"32","author":"MM Fung","year":"2010","unstructured":"Fung MM, Salem RM, Mehtani P et al (2010) Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo. Clin Exp Hypertens 32:278\u2013287. https:\/\/doi.org\/10.3109\/10641960903265246","journal-title":"Clin Exp Hypertens"},{"key":"3661_CR20","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.110.219493","volume":"107","author":"M Theurl","year":"2010","unstructured":"Theurl M, Schgoer W, Albrecht K et al (2010) The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism. Circ Res 107:1326\u20131335. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.219493","journal-title":"Circ Res"},{"key":"3661_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep44168","author":"D Zhu","year":"2017","unstructured":"Zhu D, Xie H, Wang X et al (2017) Catestatin-A novel predictor of left ventricular remodeling after acute myocardial infarction. Sci Rep. https:\/\/doi.org\/10.1038\/srep44168","journal-title":"Sci Rep"},{"key":"3661_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fphys.2014.00246","volume":"5","author":"C de Lucia","year":"2014","unstructured":"de Lucia C, Femminella GD, Gambino G et al (2014) Adrenal adrenoceptors in heart failure. Front Physiol 5:246. https:\/\/doi.org\/10.3389\/fphys.2014.00246","journal-title":"Front Physiol"},{"key":"3661_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.yjmcc.2010.11.014","volume":"51","author":"BC Jensen","year":"2011","unstructured":"Jensen BC, O\u2019Connell TD, Simpson PC (2011) Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure. J Mol Cell Cardiol 51:518\u2013528. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.11.014","journal-title":"J Mol Cell Cardiol"},{"key":"3661_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fphys.2013.00240","volume":"4","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A (2013) Physiology and pharmacology of the cardiovascular adrenergic system. Front Physiol 4:240. https:\/\/doi.org\/10.3389\/fphys.2013.00240","journal-title":"Front Physiol"},{"key":"3661_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2012.11.001","volume":"698","author":"J P\u00e9rez-Schindler","year":"2013","unstructured":"P\u00e9rez-Schindler J, Philp A, Hernandez-Cascales J (2013) Pathophysiological relevance of the cardiac \u03b22-adrenergic receptor and its potential as a therapeutic target to improve cardiac function. Eur J Pharmacol 698:39\u201347. https:\/\/doi.org\/10.1016\/j.ejphar.2012.11.001","journal-title":"Eur J Pharmacol"},{"key":"3661_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.yjmcc.2016.09.007","volume":"101","author":"S Weber","year":"2016","unstructured":"Weber S, Meyer-Roxlau S, El-Armouche A (2016) Role of protein phosphatase inhibitor-1 in cardiac beta adrenergic pathway. J Mol Cell Cardiol 101:116\u2013126. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.09.007","journal-title":"J Mol Cell Cardiol"},{"key":"3661_CR27","doi-asserted-by":"publisher","first-page":"R365","DOI":"10.1152\/ajpregu.00409.2011","volume":"302","author":"AH Gaede","year":"2012","unstructured":"Gaede AH, Pilowsky PM (2012) Catestatin, a chromogranin A-derived peptide, is sympathoinhibitory and attenuates sympathetic barosensitivity and the chemoreflex in rat CVLM. Am J Physiol Regul Integr Comp Physiol 302:R365\u2013R372. https:\/\/doi.org\/10.1152\/ajpregu.00409.2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3661_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/0929867321666141106114928","volume":"22","author":"R Mazza","year":"2015","unstructured":"Mazza R, Tota B, Gattuso A (2015) Cardio-vascular activity of catestatin: interlocking the puzzle pieces. Curr Med Chem 22:292\u2013304","journal-title":"Curr Med Chem"},{"key":"3661_CR29","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1210\/en.2008-0318","volume":"149","author":"T Angelone","year":"2008","unstructured":"Angelone T, Quintieri AM, Brar BK et al (2008) The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine\/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 149:4780\u20134793. https:\/\/doi.org\/10.1210\/en.2008-0318","journal-title":"Endocrinology"},{"key":"3661_CR30","doi-asserted-by":"publisher","first-page":"H431","DOI":"10.1152\/ajpheart.00491.2011","volume":"302","author":"T Angelone","year":"2012","unstructured":"Angelone T, Quintieri AM, Pasqua T et al (2012) Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin. Am J Physiol Heart Circ Physiol 302:H431\u2013H442. https:\/\/doi.org\/10.1152\/ajpheart.00491.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3661_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.freeradbiomed.2010.03.014","volume":"49","author":"JV Rodrigues","year":"2010","unstructured":"Rodrigues JV, Gomes CM (2010) Enhanced superoxide and hydrogen peroxide detection in biological assays. Free Radic Biol Med 49:61\u201366. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.03.014","journal-title":"Free Radic Biol Med"},{"key":"3661_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nprot.2009.197","volume":"5","author":"CJ Weydert","year":"2010","unstructured":"Weydert CJ, Cullen JJ (2010) Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 5:51\u201366. https:\/\/doi.org\/10.1038\/nprot.2009.197","journal-title":"Nat Protoc"},{"key":"3661_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem FEBS 47:469\u2013474","journal-title":"Eur J Biochem FEBS"},{"key":"3661_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/ars.2006.8.1081","volume":"8","author":"MK Gupta","year":"2006","unstructured":"Gupta MK, Neelakantan TV, Sanghamitra M et al (2006) An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts. Antioxid Redox Signal 8:1081\u20131093. https:\/\/doi.org\/10.1089\/ars.2006.8.1081","journal-title":"Antioxid Redox Signal"},{"key":"3661_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-017-3088-8","author":"N Saleem","year":"2017","unstructured":"Saleem N, Goswami SK (2017) Activation of adrenergic receptor in H9c2 cardiac myoblasts co-stimulates Nox2 and the derived ROS mediate the downstream responses. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-017-3088-8","journal-title":"Mol Cell Biochem"},{"key":"3661_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119790","author":"E Bassino","year":"2015","unstructured":"Bassino E, Fornero S, Gallo MP et al (2015) Catestatin exerts direct protective effects on rat cardiomyocytes undergoing ischemia\/reperfusion by stimulating PI3K-Akt-GSK3\u03b2 pathway and preserving mitochondrial membrane potential. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0119790","journal-title":"PLoS ONE"},{"key":"3661_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep16590","author":"F Liao","year":"2015","unstructured":"Liao F, Zheng Y, Cai J et al (2015) Catestatin attenuates endoplasmic reticulum induced cell apoptosis by activation type 2 muscarinic acetylcholine receptor in cardiac ischemia\/reperfusion. Sci Rep. https:\/\/doi.org\/10.1038\/srep16590","journal-title":"Sci Rep"},{"key":"3661_CR38","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","volume":"1832","author":"E Dirkx","year":"2013","unstructured":"Dirkx E, da Costa Martins PA, De Windt LJ (2013) Regulation of fetal gene expression in heart failure. Biochim Biophys Acta 1832:2414\u20132424. https:\/\/doi.org\/10.1016\/j.bbadis.2013.07.023","journal-title":"Biochim Biophys Acta"},{"key":"3661_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2017.07.027","author":"GN Kanaan","year":"2017","unstructured":"Kanaan GN, Harper ME (2017) Cellular redox dysfunction in the development of cardiovascular diseases. Biochim Biophys Acta. https:\/\/doi.org\/10.1016\/j.bbagen.2017.07.027","journal-title":"Biochim Biophys Acta"},{"key":"3661_CR40","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.freeradbiomed.2011.07.008","volume":"51","author":"E Jindal","year":"2011","unstructured":"Jindal E, Goswami SK (2011) In cardiac myoblasts, cellular redox regulates FosB and Fra-1 through multiple cis-regulatory modules. Free Radic Biol Med 51:1512\u20131521. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.07.008","journal-title":"Free Radic Biol Med"},{"key":"3661_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11010-017-3253-0","volume":"445","author":"N Saleem","year":"2018","unstructured":"Saleem N, Prasad A, Goswami SK (2018) Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat. Mol Cell Biochem 445:79\u201388. https:\/\/doi.org\/10.1007\/s11010-017-3253-0","journal-title":"Mol Cell Biochem"},{"key":"3661_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.redox.2015.05.005","volume":"5","author":"A Thakur","year":"2015","unstructured":"Thakur A, Alam MJ, Ajayakumar MR et al (2015) Norepinephrine-induced apoptotic and hypertrophic responses in H9c2 cardiac myoblasts are characterized by different repertoire of reactive oxygen species generation. Redox Biol 5:243\u2013252. https:\/\/doi.org\/10.1016\/j.redox.2015.05.005","journal-title":"Redox Biol"},{"key":"3661_CR43","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1083\/jcb.201708007","volume":"217","author":"Y Wang","year":"2018","unstructured":"Wang Y, Branicky R, No\u00eb A, Hekimi S (2018) Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol 217:1915\u20131928. https:\/\/doi.org\/10.1083\/jcb.201708007","journal-title":"J Cell Biol"},{"key":"3661_CR44","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.114.302849","volume":"114","author":"A Cabassi","year":"2014","unstructured":"Cabassi A, Binno SM, Tedeschi S et al (2014) Low serum ferroxidase I activity is associated with mortality in heart failure and related to both peroxynitrite-induced cysteine oxidation and tyrosine nitration of ceruloplasmin. Circ Res 114:1723\u20131732. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302849","journal-title":"Circ Res"},{"key":"3661_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4149\/gpb_2013016","volume":"32","author":"H Paulova","year":"2013","unstructured":"Paulova H, Stracina T, Jarkovsky J et al (2013) Hydroxyl radicals\u2019 production and ECG parameters during ischemia and reperfusion in rat, guinea pig and rabbit isolated heart. Gen Physiol Biophys 32:221\u2013228. https:\/\/doi.org\/10.4149\/gpb_2013016","journal-title":"Gen Physiol Biophys"},{"key":"3661_CR46","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","volume":"86","author":"H Sies","year":"2017","unstructured":"Sies H, Berndt C, Jones DP (2017) Oxidative Stress. Annu Rev Biochem 86:715\u2013748. https:\/\/doi.org\/10.1146\/annurev-biochem-061516-045037","journal-title":"Annu Rev Biochem"},{"issue":"Suppl 1","key":"3661_CR47","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.33549\/physiolres.933403","volume":"65","author":"M Baran\u010d\u00edk","year":"2016","unstructured":"Baran\u010d\u00edk M, Gre\u0161ov\u00e1 L, Bartekov\u00e1 M, Dovinov\u00e1 I (2016) Nrf2 as a key player of redox regulation in cardiovascular diseases. Physiol Res 65(Suppl 1):S1\u2013S10","journal-title":"Physiol Res"},{"key":"3661_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.18433\/J3N318","volume":"18","author":"C Gang","year":"2015","unstructured":"Gang C, Qiang C, Xiangli C et al (2015) Puerarin suppresses angiotensin II-induced cardiac hypertrophy by inhibiting NADPH oxidase activation and oxidative stress-triggered AP-1 signaling pathways. J Pharm Pharm Sci 18:235\u2013248","journal-title":"J Pharm Pharm Sci"},{"key":"3661_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/cvr\/cvt094","volume":"99","author":"C Hill","year":"2013","unstructured":"Hill C, W\u00fcrfel A, Heger J et al (2013) Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction. Cardiovasc Res 99:121\u2013128. https:\/\/doi.org\/10.1093\/cvr\/cvt094","journal-title":"Cardiovasc Res"},{"key":"3661_CR50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R117.800169","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Yamamoto M (2017) Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.R117.800169","journal-title":"J Biol Chem"},{"key":"3661_CR51","doi-asserted-by":"publisher","first-page":"e73294","DOI":"10.1371\/journal.pone.0073294","volume":"8","author":"R Windak","year":"2013","unstructured":"Windak R, M\u00fcller J, Felley A et al (2013) The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart. PLoS ONE 8:e73294. https:\/\/doi.org\/10.1371\/journal.pone.0073294","journal-title":"PLoS ONE"},{"key":"3661_CR52","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1128\/MCB.00982-14","volume":"35","author":"N Selvaraj","year":"2015","unstructured":"Selvaraj N, Budka JA, Ferris MW et al (2015) Extracellular signal-regulated kinase signaling regulates the opposing roles of JUN family transcription factors at ETS\/AP-1 sites and in cell migration. Mol Cell Biol 35:88\u2013100. https:\/\/doi.org\/10.1128\/MCB.00982-14","journal-title":"Mol Cell Biol"},{"key":"3661_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/imr.12199","volume":"261","author":"P Li","year":"2014","unstructured":"Li P, Spolski R, Liao W, Leonard WJ (2014) Complex interactions of transcription factors in mediating cytokine biology in T cells. Immunol Rev 261:141\u2013156. https:\/\/doi.org\/10.1111\/imr.12199","journal-title":"Immunol Rev"},{"key":"3661_CR54","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0008-6363(01)00348-0","volume":"51","author":"T Fujita","year":"2001","unstructured":"Fujita T, Toya Y, Iwatsubo K et al (2001) Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc Res 51:709\u2013716","journal-title":"Cardiovasc Res"},{"key":"3661_CR55","doi-asserted-by":"publisher","first-page":"12033","DOI":"10.1073\/pnas.1712612114","volume":"114","author":"I Gesmundo","year":"2017","unstructured":"Gesmundo I, Miragoli M, Carullo P et al (2017) Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure. Proc Natl Acad Sci USA 114:12033\u201312038. https:\/\/doi.org\/10.1073\/pnas.1712612114","journal-title":"Proc Natl Acad Sci USA"},{"key":"3661_CR56","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nchembio726","volume":"1","author":"A Ianoul","year":"2005","unstructured":"Ianoul A, Grant DD, Rouleau Y et al (2005) Imaging nanometer domains of beta-adrenergic receptor complexes on the surface of cardiac myocytes. Nat Chem Biol 1:196\u2013202. https:\/\/doi.org\/10.1038\/nchembio726","journal-title":"Nat Chem Biol"},{"key":"3661_CR57","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejphar.2017.11.049","volume":"819","author":"FS Vyas","year":"2018","unstructured":"Vyas FS, Nelson CP, Dickenson JM (2018) Role of transglutaminase 2 in A1 adenosine receptor- and \u03b22-adrenoceptor-mediated pharmacological pre- and post-conditioning against hypoxia-reoxygenation-induced cell death in H9c2 cells. Eur J Pharmacol 819:144\u2013160. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.049","journal-title":"Eur J Pharmacol"},{"key":"3661_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.top070318","author":"LC Crowley","year":"2016","unstructured":"Crowley LC, Marfell BJ, Scott AP et al (2016) Dead cert: measuring cell death. Cold Spring Harb Protoc. https:\/\/doi.org\/10.1101\/pdb.top070318","journal-title":"Cold Spring Harb Protoc"},{"key":"3661_CR59","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.biocel.2008.02.020","volume":"40","author":"SP Barry","year":"2008","unstructured":"Barry SP, Davidson SM, Townsend PA (2008) Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 40:2023\u20132039. https:\/\/doi.org\/10.1016\/j.biocel.2008.02.020","journal-title":"Int J Biochem Cell Biol"},{"key":"3661_CR60","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2741\/e484","volume":"4","author":"Y Fu","year":"2012","unstructured":"Fu Y, Xiao H, Zhang Y (2012) Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling. Front Biosci Elite Ed 4:1625\u20131637","journal-title":"Front Biosci Elite Ed"},{"key":"3661_CR61","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/pr.112.007203","volume":"66","author":"TD O\u2019Connell","year":"2014","unstructured":"O\u2019Connell TD, Jensen BC, Baker AJ, Simpson PC (2014) Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance. Pharmacol Rev 66:308\u2013333. https:\/\/doi.org\/10.1124\/pr.112.007203","journal-title":"Pharmacol Rev"},{"key":"3661_CR62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.redox.2015.06.014","volume":"5","author":"G Manda","year":"2015","unstructured":"Manda G, Isvoranu G, Comanescu MV et al (2015) The redox biology network in cancer pathophysiology and therapeutics. Redox Biol 5:347\u2013357. https:\/\/doi.org\/10.1016\/j.redox.2015.06.014","journal-title":"Redox Biol"},{"key":"3661_CR63","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1021\/bi401719r","volume":"53","author":"NY Spencer","year":"2014","unstructured":"Spencer NY, Engelhardt JF (2014) The basic biology of redoxosomes in cytokine-mediated signal transduction and implications for disease-specific therapies. Biochemistry 53:1551\u20131564. https:\/\/doi.org\/10.1021\/bi401719r","journal-title":"Biochemistry"},{"key":"3661_CR64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cardfail.2005.01.007","volume":"11","author":"F Sam","year":"2005","unstructured":"Sam F, Kerstetter DL, Pimental DR et al (2005) Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 11:473\u2013480. https:\/\/doi.org\/10.1016\/j.cardfail.2005.01.007","journal-title":"J Card Fail"},{"key":"3661_CR65","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cardiores.2007.02.016","volume":"74","author":"S Srivastava","year":"2007","unstructured":"Srivastava S, Chandrasekar B, Gu Y et al (2007) Downregulation of CuZn-superoxide dismutase contributes to beta-adrenergic receptor-mediated oxidative stress in the heart. Cardiovasc Res 74:445\u2013455. https:\/\/doi.org\/10.1016\/j.cardiores.2007.02.016","journal-title":"Cardiovasc Res"},{"key":"3661_CR66","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1161\/HYPERTENSIONAHA.116.06568","volume":"68","author":"M Kiranmayi","year":"2016","unstructured":"Kiranmayi M, Chirasani VR, Allu PKR et al (2016) Catestatin Gly364Ser variant alters systemic blood pressure and the risk for hypertension in human populations via endothelial nitric oxide pathway. Hypertens Dallas Tex 68:334\u2013347. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.06568","journal-title":"Hypertens Dallas Tex"},{"key":"3661_CR67","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1242\/jcs.103176","volume":"125","author":"BS Sahu","year":"2012","unstructured":"Sahu BS, Mohan J, Obbineni JM et al (2012) Molecular interactions of the physiological anti-hypertensive peptide catestatin with the neuronal nicotinic acetylcholine receptor. J Cell Sci 125:2323\u20132337. https:\/\/doi.org\/10.1242\/jcs.103176","journal-title":"J Cell Sci"},{"key":"3661_CR68","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.celrep.2016.07.063","volume":"16","author":"SF Schmidt","year":"2016","unstructured":"Schmidt SF, Madsen JG, Frafjord KO et al (2016) Integrative genomics outlines a biphasic glucose response and a ChREBP-RORgamma axis regulating proliferation in beta cells. Cell Rep 16:2359\u20132372. https:\/\/doi.org\/10.1016\/j.celrep.2016.07.063","journal-title":"Cell Rep"},{"key":"3661_CR69","doi-asserted-by":"publisher","first-page":"e41613","DOI":"10.1371\/journal.pone.0041613","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang X, Meng J, Wang ZY (2012) A switch role of Src in the biphasic EGF signaling of ER-negative breast cancer cells. PLoS ONE 7:e41613. https:\/\/doi.org\/10.1371\/journal.pone.0041613","journal-title":"PLoS ONE"},{"key":"3661_CR70","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/00005344-198912000-00013","volume":"14","author":"MG Kazanietz","year":"1989","unstructured":"Kazanietz MG, Gutkind JS, Puyo A et al (1989) Further evidence of interaction between vasodilator beta 2- and vasoconstrictor alpha 2-adrenoceptor-mediated responses in maintaining vascular tone in anesthetized rats. J Cardiovasc Pharmacol 14:874\u2013880","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03661-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03661-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03661-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T19:22:15Z","timestamp":1606764135000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03661-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3661"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03661-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}